These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 37052759

  • 1. Site-Specific Photoaffinity Bioconjugation for the Creation of 89Zr-Labeled Radioimmunoconjugates.
    Delaney S, Nagy Á, Karlström AE, Zeglis BM.
    Mol Imaging Biol; 2023 Dec; 25(6):1104-1114. PubMed ID: 37052759
    [Abstract] [Full Text] [Related]

  • 2. Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates.
    Sarrett SM, Rodriguez C, Rymarczyk G, Hosny MM, Keinänen O, Delaney S, Thau S, Krantz BA, Zeglis BM.
    Bioconjug Chem; 2022 Sep 21; 33(9):1750-1760. PubMed ID: 35946495
    [Abstract] [Full Text] [Related]

  • 3. The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of 89Zr-DFO-Pertuzumab.
    Vivier D, Fung K, Rodriguez C, Adumeau P, Ulaner GA, Lewis JS, Sharma SK, Zeglis BM.
    Theranostics; 2020 Sep 21; 10(4):1746-1757. PubMed ID: 32042334
    [Abstract] [Full Text] [Related]

  • 4. Cadherin-17 as a target for the immunoPET of adenocarcinoma.
    Delaney S, Keinänen O, Lam D, Wolfe AL, Hamakubo T, Zeglis BM.
    Eur J Nucl Med Mol Imaging; 2024 Jul 21; 51(9):2547-2557. PubMed ID: 38625402
    [Abstract] [Full Text] [Related]

  • 5. A Systematic Evaluation of Antibody Modification and 89Zr-Radiolabeling for Optimized Immuno-PET.
    Sharma SK, Glaser JM, Edwards KJ, Khozeimeh Sarbisheh E, Salih AK, Lewis JS, Price EW.
    Bioconjug Chem; 2021 Jul 21; 32(7):1177-1191. PubMed ID: 32197571
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET.
    Sharma SK, Adumeau P, Keinänen O, Sisodiya V, Sarvaiya H, Tchelepi R, Korsen JA, Pourat J, Edwards KJ, Ragupathi A, Hamdy O, Saunders LR, Rudin CM, Poirier JT, Lewis JS, Zeglis BM.
    Bioconjug Chem; 2021 Jul 21; 32(7):1255-1262. PubMed ID: 33835770
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Light-Induced Radiosynthesis of 89Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor.
    Klingler S, Fay R, Holland JP.
    J Nucl Med; 2020 Jul 21; 61(7):1072-1078. PubMed ID: 31924725
    [Abstract] [Full Text] [Related]

  • 14. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.
    Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS.
    J Nucl Med; 2010 Aug 21; 51(8):1293-300. PubMed ID: 20660376
    [Abstract] [Full Text] [Related]

  • 15. 89Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe.
    Fung K, Vivier D, Keinänen O, Sarbisheh EK, Price EW, Zeglis BM.
    Molecules; 2020 May 15; 25(10):. PubMed ID: 32429033
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Site-selective radiolabeling using mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition.
    Rodriguez C, Delaney S, Sebastiano J, Sarrett SM, Cornejo MA, Thau S, Hosny MM, Zeglis BM.
    RSC Adv; 2023 Jun 09; 13(26):17705-17709. PubMed ID: 37313000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.